价格

phosphodiesterase inhibitor (respiratory disease)

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Combinations comprising antimuscarinic agents and beta-adrenergic agonists
EP 2774623 B1申请人: ALMIRALL SA优先权: 2004
CN
EP
13 件公开
Metabolite of xanthine Phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction
US 7312223 B2申请人: SCHERING CORP优先权: 2003
CN
US
3 件公开
Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
EP 2484382 A1申请人: SCHERING CORP优先权: 2006
EP
US
2 件公开
PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A SECOND ACTIVE INGREDIENT
US 2011207770 A1申请人: ASTRAZENECA AB优先权: 2008
CN
US
2 件公开
8-(Biaryl)quinoline pde4 inhibitors
US 2005234238 A1申请人: DUBE DANIEL优先权: 2004
US
2 件公开
Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders
US 2003069169 A1申请人: MACOR JOHN E优先权: 2002
US
Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors
US 2003158189 A1申请人: MARFAT ANTHONY优先权: 2002
US
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
- US 2005026883 A1
  申请人: ROBINSON CYNTHIA B优先权: 2003
  US
- US 2005085430 A1
  申请人: ROBINSON CYNTHIA B优先权: 2004
  US
- US 2009274676 A1
  申请人: ROBINSON CYNTHIA B优先权: 2008
  US
Dry powder formulation comprising a phosphodiesterase inhibitor
CN 103052379 A申请人: CHIESI FARMA SPA优先权: 2011
CN
METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PNEUMONIA, BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, PULMONARY ARTERIAL HYPERTENSION, ADN RESPIRATORY SYNCYTIAL VIRUS
US 20260007656 A1申请人: REVERSPAH LLC优先权: 2025
US

药物

phosphodiesterase inhibitor (respiratory disease)

专利

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease